Your browser doesn't support javascript.
loading
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.
Sapienza, Maria Rosaria; Abate, Francesco; Melle, Federica; Orecchioni, Stefania; Fuligni, Fabio; Etebari, Maryam; Tabanelli, Valentina; Laginestra, Maria Antonella; Pileri, Alessandro; Motta, Giovanna; Rossi, Maura; Agostinelli, Claudio; Sabattini, Elena; Pimpinelli, Nicola; Truni, Mauro; Falini, Brunangelo; Cerroni, Lorenzo; Talarico, Giovanna; Piccioni, Rossana; Amente, Stefano; Indio, Valentina; Tarantino, Giuseppe; Brundu, Francesco; Paulli, Marco; Berti, Emilio; Facchetti, Fabio; Dellino, Gaetano Ivan; Bertolini, Francesco; Tripodo, Claudio; Rabadan, Raul; Pileri, Stefano A.
Afiliación
  • Sapienza MR; Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy mariarosaria.sapienza@gmail.com.
  • Abate F; Department of Systems Biology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
  • Melle F; Department of Biomedical Informatics, Columbia University College of Physicians and Surgeons, New York, NY, USA.
  • Orecchioni S; Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Fuligni F; Laboratory of Hematology-Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Etebari M; Department of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
  • Tabanelli V; Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy.
  • Laginestra MA; Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Pileri A; Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy.
  • Motta G; Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.
  • Rossi M; Division of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Italy.
  • Agostinelli C; Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Sabattini E; Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy.
  • Pimpinelli N; Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy.
  • Truni M; Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy.
  • Falini B; Division of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Italy.
  • Cerroni L; Pathological Anatomy Histology & Cytogenetics, Niguarda Cancer Center, Niguarda-Ca' Granda Hospital, Milan, Italy.
  • Talarico G; Institute of Hematology and Center for Hemato-Oncology Research (CREO), University and Hospital of Perugia, Italy.
  • Piccioni R; Universitätsklinik für Dermatologie und Venerologie, LKH-Universitatsklinikum Graz, Austria.
  • Amente S; Laboratory of Hematology-Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Indio V; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
  • Tarantino G; Department of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Italy.
  • Brundu F; "Giorgio Prodi" Cancer Research Center, University of Bologna, Italy.
  • Paulli M; "Giorgio Prodi" Cancer Research Center, University of Bologna, Italy.
  • Berti E; Department of Systems Biology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
  • Facchetti F; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Policlinic, Pavia, Italy.
  • Dellino GI; Department of Dermatology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinic and Milan University, Milan, Italy.
  • Bertolini F; Pathology Section, Department of Molecular and Translational Medicine, University of Brescia, Italy.
  • Tripodo C; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
  • Rabadan R; Department of Oncology and Hemato-Oncology, University of Milan, Italy.
  • Pileri SA; Laboratory of Hematology-Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
Haematologica ; 104(4): 729-737, 2019 04.
Article en En | MEDLINE | ID: mdl-30381297
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Azacitidina / Regulación Neoplásica de la Expresión Génica / Neoplasias Hematológicas / Epigénesis Genética / Decitabina / Trastornos Mieloproliferativos / Proteínas de Neoplasias Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Azacitidina / Regulación Neoplásica de la Expresión Génica / Neoplasias Hematológicas / Epigénesis Genética / Decitabina / Trastornos Mieloproliferativos / Proteínas de Neoplasias Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article